Published in Ann Hepatol on March 23, 2010
Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget (2015) 0.99
Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg (2015) 0.96
Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol (2013) 0.88
Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Lett (2015) 0.79
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol (2012) 3.88
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med (2015) 3.16
Management of chronic hepatitis C: consensus guidelines. Can J Gastroenterol (2007) 2.06
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol (2002) 1.94
Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg (2009) 1.91
Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol (2007) 1.78
Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol (2003) 1.67
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Epidemiology, presentation, diagnosis, and outcomes of choledochal cysts in adults in an urban environment. Am J Surg (2005) 1.62
Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth (2005) 1.55
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl (2002) 1.51
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4. Liver Int (2014) 1.42
Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantation. Clin Transplant (2007) 1.39
A tumescent twist to breast augmentation. Plast Reconstr Surg (2002) 1.38
Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood (2007) 1.28
Epithelioid angiosarcoma of the small bowel. Gastrointest Endosc (2006) 1.26
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer (2010) 1.22
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma (2005) 1.21
Choledochal cysts. Part 3 of 3: management. Can J Surg (2010) 1.21
Loss of PTEN is associated with progression to androgen independence. Prostate (2006) 1.20
Choledochal cysts: analysis of disease pattern and optimal treatment in adult and paediatric patients. HPB (Oxford) (2007) 1.20
ALPPS: Adverse Outcomes Demand Clear Justification in an Era of Improving Survival for Colorectal Liver Metastases. World J Surg (2015) 1.18
Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res (2003) 1.15
Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett (2005) 1.11
Surgeons' anonymous response after bile duct injury during cholecystectomy. Am J Surg (2003) 1.09
Multidisciplinary management of ruptured hepatocellular carcinoma. J Gastrointest Surg (2006) 1.07
Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways. Cell Signal (2007) 1.05
Choledochal cysts: part 2 of 3: Diagnosis. Can J Surg (2009) 1.03
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009. PLoS One (2012) 1.02
Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transpl (2002) 1.01
Characteristics of primary biliary cirrhosis in British Columbia's First Nations population. Can J Gastroenterol (2005) 1.01
Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review. Ann Hepatol (2012) 0.99
Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol (2008) 0.99
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int (2005) 0.98
Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl (2002) 0.96
Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol (2010) 0.94
Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels. J Biol Chem (2003) 0.94
Perioperative analysis of laparoscopic versus open liver resection. Surg Endosc (2009) 0.94
Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance? Dig Dis Sci (2002) 0.93
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection. Gastroenterology (2013) 0.92
Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic {beta}-cells. Am J Physiol Gastrointest Liver Physiol (2009) 0.92
Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Res (2006) 0.92
Spontaneous intramural esophageal hematoma: case report and review. Can J Gastroenterol (2006) 0.92
Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg Pathol (2015) 0.91
Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma. Virchows Arch (2010) 0.91
Late acute celiac and hepatic artery thrombosis with portal vein thrombosis resulting in hepatic infarction 12 years post orthotopic liver transplantation. Ann Hepatol (2009) 0.91
PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15. Mol Cell Biol (2008) 0.90
A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg (2002) 0.90
Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol (2009) 0.88
When there is not plenty for everyone: options for reconstructing a suprahepatic vena cava injured during organ procurement. Liver Transpl (2013) 0.87
The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int J Circumpolar Health (2004) 0.86
Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? A case report and review of the literature. Ann Hepatol (2010) 0.86
Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation. J Interferon Cytokine Res (2006) 0.85
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Liver Transpl (2003) 0.85
Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett (2003) 0.85
Hepatocellular carcinoma with cutaneous metastases. Can J Gastroenterol (2009) 0.85
Computed tomography and angiographic interventional features of ruptured hepatocellular carcinoma: pictorial essay. Can Assoc Radiol J (2006) 0.85
LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res (2009) 0.85
Racial differences in the incidence of colorectal cancer. Can J Gastroenterol (2010) 0.84
The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. Histopathology (2012) 0.84
Hepatic artery transection reconstructed with splenic artery transposition graft. Perspect Vasc Surg Endovasc Ther (2012) 0.84
First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. Ann Hepatol (2013) 0.83
Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open (2013) 0.83